Friday 1 November 12h45 – 14h15
Hotel Le Méridien Etoile, 81 Boulevard Gouvion-Saint-Cyr, Paris (directly near the Palais des Congrès in Paris where the 44th Union World Conference on Lung Health will be held)
Worldwide millions of people suffer from TB. Many heart-breaking stories can be told about the disease which heavily impacts people, their families and communities. But besides the huge human suffering, there is also a financial urgency to eliminate TB.
Prof Roland Diel from the University Hospital Schleswig-Holstein in Kiel and member of the Board of the German central committee against TB, calculated the economic burden of TB in Europe. His conservative calculation: TB costs the EU € 5.9 billion per year.
Dr Mario Raviglione, Director of the Stop TB Department of WHO, is responsible for the strategy to stop this devastating disease. He will talk about the pathway to eliminate TB: why we need new new tools (including vaccines).
The Global Health & Technology Coalition (GHTC) recently published a paper about the funding landscape for global health research and development (R&D). Claire Wingfield of the GHTC will present key financing challenges and opportunities facing product development partnerships and other non-profit product developers that advance the development of new vaccines, drugs, diagnostics, microbicides, and devices for low- and middle-income countries.
Theserenowned experts will explain their findings and vision in a short presentation. We invite you to join this meeting and join the discussion in how to reach the goal of elimination. The discussion will be moderated by Prof Michel Kazatchkine, Special Envoy of the UN Secretary General on HIV/AIDS in Eastern Europe and Central Asia, and former Executive Director of The Global Fund.
A small lunch will be provided.
Decision makers in global health, politicians, policy makers and global health advocates are invited to join the discussion. If you would like to join this meeting, please register before 29 October.
Note: registration for the 44th Union meeting is not required.
Source: TuBerculosis Vaccine Initiative